Publications by authors named "Jiaai Fu"

Tumor growth and metastasis heavily rely on angiogenesis, crucial for solid tumor development. Inhibiting angiogenesis associated with tumors emerges as a potent therapeutic approach. Our previous work synthesized the chondroitin sulfate-modified antiangiogenic peptide CS-ES2-AF (CS-EA), which exhibited better antiangiogenic activity, longer half-life, and more robust targeting.

View Article and Find Full Text PDF
Article Synopsis
  • Neovascularization plays a key role in tumor development, making antiangiogenic drugs important for cancer treatment, though they are not sufficient on their own.
  • This research introduces a new nanodrug (CCEA) that combines chondroitin sulfate, an antiangiogenic peptide, and the chemotherapeutic drug cisplatin, demonstrating enhanced targeting and reduced toxicity for tumor treatment.
  • CCEA effectively induces tumor cell death by activating pro-apoptotic factors and inhibiting anti-apoptotic signals, offering promising insights for future cancer therapies.
View Article and Find Full Text PDF

Chitin is a natural polymeric polysaccharide extracted from marine crustaceans, and chitosan is obtained by removing part of the acetyl group (usually more than 60 %) in chitin's structure. Chitosan has attracted wide attention from researchers worldwide due to its good biodegradability, biocompatibility, hypoallergenic and biological activities (antibacterial, immune and antitumor activities). However, research has shown that chitosan does not melt or dissolve in water, alkaline solutions and general organic solvents, which greatly limits its application range.

View Article and Find Full Text PDF

The progression and metastasis of solid tumors rely strongly on neovascularization. However, angiogenesis inhibitors alone cannot meet the needs of tumor therapy. This study prepared a new drug conjugate (PTX-GSHP-CYS-ES2, PGCE) by combining polysaccharides (heparin without anticoagulant activity, GSHP), chemotherapeutic drugs (paclitaxel, PTX), and antiangiogenic drugs (ES2).

View Article and Find Full Text PDF

In recent years, the development and applications of protein drugs have attracted extensive attention from researchers. However, the shortcomings of protein drugs also limit their further development. Therefore, bioactive peptides isolated or simulated from protein polymers have broad application prospects in food, medicine, biotechnology, and other industries.

View Article and Find Full Text PDF